DANIEL
ORTEGA PONCE

I obtained my BSC degree in Chemistry of Materials, MSc degree in Industrial Process Engineering and PhD in Condensed Matter Physics at the University of Cadiz in 2001, 2003 and 2007, respectively, focusing on the development of new nanocomposites for magneto-optical current sensors. During this period, I conducted different research placements at the University of the Basque Country and the University of Porto for advanced training in ferromagnetic resonance, SQUID magnetometry and Mössbauer spectroscopy for characterising magnetic nanomaterials. In 2008 I joined the University of the Basque Country as a research associate working on the anomalous magnetic properties of metal nanoparticles. In 2009 I was awarded a Marie Curie post-doctoral contract to join the Physics department at the University College London (UCL) and the Royal Institution of Great Britain in London for three years. During this time, I specialised in the application of magnetic nanoparticles in biomedicine, in particular in hyperthermia for cancer therapy, as well as in tissue engineering and cellular therapies based on magnetically-tagged mesenchymal stem cells. I was a research associate at the EIIRIS institute of the University of Toyohashi in 2013 developing a new modality of liquid electron microscopy for characterising the interaction between cells and magnetic nanomaterials in their native state. Later that year, I joined IMDEA Nanoscience as a research assistant professor through an AMAROUT Europe Marie Curie Action and became leader of the Applied Nanomagnetics group. I was appointed honorary research fellow to the London Centre for Nanotechnology (2010-2013 & 2016-2018), and later to the UCL Institute of Biomedical Engineering (2013 - 2015). As of January 2020, I’m a Ramón y Cajal researcher at the Condensed Matter Physics dept. of UCA. With deep research interests in nanomedicine, I was the vice-coordinator of the COST action "RADIOMAG" between 2014 and 2018, the largest European network dedicated to the combination of magnetic hyperthermia. I’m currently the coordinator of the national network of Nanotechnology in Translational Hyperthermia, as well as a member of the management committee of the COST action "MyWAVE" on electromagnetic hyperthermia. I’m the leader of the recently founded Nanoteranostics group at the INiBICA, continue to lead the Applied Nanomagnetics group at IMDEA Nanoscience and I’m the scientist in charge of the regional RedLab In Silico Electromagnetic Testing Laboratory in Madrid. In addition, I have been elected member of the EPSRC Peer Review College and serve as an expert evaluator for the European Commission and other research organisations in Spain, France, UK, Chile, Romania, Czech Republic, Slovakia, Slovenia and Hungary. Also having an international profile as a communicator, I have delivered 15 invited talks at international conferences, participated as speaker in several special dissemination events - like the “Beating Cancer by 2030: Mission Impossible?” at the COST office in Brussels – and organized/chaired several sessions at major international conferences (E-MRS, MMM, JEMS, Intermag, etc.), being chair and organiser of the international NALS 2020 and ESHO 2024 conferences.